PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Nature Communications18 citationsOpen Access

A multimodal dataset for precision oncology in head and neck cancer

View Full Paper
MDMarion DörrichFriedrich-Alexander-Universität Erlangen-NürnbergMBMatthias BalkFriedrich-Alexander-Universität Erlangen-NürnbergTHTatjana HeusingerFriedrich-Alexander-Universität Erlangen-Nürnberg

Key Points

  • Combining multiple data types improved endpoint prediction in head and neck cancer patients, enhancing treatment outcomes.
  • The dataset includes demographical, pathological, and blood data, as well as surgical reports and histologic images for in-depth analysis.
  • Using machine learning algorithms on this multimodal dataset demonstrated superiority compared to single-modality approaches.
  • HANCOCK intends to facilitate further research in precision oncology by providing a robust resource for multimodal machine learning.

Abstract

Abstract Head and neck cancer is a common disease and is associated with a poor prognosis. A promising approach to improving patient outcomes is personalized treatment, which uses information from a variety of modalities. However, only little progress has been made due to the lack of large public datasets. We present a multimodal dataset, HANCOCK, that comprises monocentric, real-world data of 763 head and neck cancer patients. Our dataset contains demographical, pathological, and blood data as well as surgery reports and histologic images, that can be explored in a low-dimensional representation. We can show that combining these modalities using machine learning is superior to a single modality and the integration of imaging data using foundation models helps in endpoint prediction. We believe that HANCOCK will not only open new insights into head and neck cancer pathology but also serve as a major source for researching multimodal machine-learning methodologies in precision oncology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dörrich et al. (2025) studied this question.

synapsesocial.com/papers/68c1b18554b1d3bfb60e82d6https://doi.org/10.1038/s41467-025-62386-6
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy2020 · 476 citations
  2. 2Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study2019 · 3,328 citations
  3. 3Deep texture representation analysis for histopathological images2023 · 5 citations
  4. 4The role of AI for developing digital twins in healthcare: The case of cancer care2022 · 108 citations
  5. 5Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer2010 · 6,610 citations